Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades. Early life Born Minesh Prafulchandra Mehta in Uganda, December 14, 1957, to two teachers from India. After moving to Zambia, he completed high school, and enrolled in the pre-medical curriculum, graduating with a Bachelor's degree in Human Biology from the University of Zambia. He completed a residency at the University of Wisconsin, where he served as chief resident in radiation oncology. Career Mehta is currently deputy director and chief of radiation oncology at Miami Cancer Institute at Baptist Health South Florida. Until January 2016, he served as medical director of the Maryland Proton Treatment Center at University of Maryland School of Medicine in Baltimore launching, the area’s first proton treatment center. Prior to this till 2013 at Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, he was co-director of the Radiation Oncology Residency Training Program, mentoring many young physicians who have gone on to become prominent leaders in the field. He has designed and led numerous national and international clinical studies, receiving NIH and NCI grants and winning several honors, many for his research in brain and central nervous system tumors. In 1988, after completing his residency training at the University of Wisconsin, he joined the Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison as an assistant professor, eventually becoming tenured Professor and Department Chair by 1997. Among his many accomplishments were the scientific and clinical implementation of image-guided intensity modulated radiotherapy through an NIH-funded Program Project Grant, overseeing the development of robust translational programs combining radiotherapy with targeted agents integrating advanced imaging (he was the Principal Investigator for the Imaging and Radiation Sciences Program of the University of Wisconsin Cancer Center for 15 years), and providing national and international leadership in Brain Tumor Clinical Trials through his leadership of the Brain Tumor Committee of the Radiation Therapy Oncology Group (RTOG). The RTOG Brain Tumor Committee arguably became the most comprehensive clinical trial co-operative group committee for this disease category, completing the largest ever randomized trial in Glioblastoma, incorporating patient-specific, advanced-imaging, molecular, and cognitive/quality-of-life endpoints. Additionally, through his work in the RTOG and other clinical trial mechanisms he was instrumental in setting new standards